J Korean Med Sci.  2010 Aug;25(8):1231-1233. 10.3346/jkms.2010.25.8.1231.

A Case of Anaphylaxis to Oral Minocycline

• Jang JW
• Bae YJ
• Kim YG
• Jin YJ
• Park KS
• Cho YS
• Moon HB
• Kim TB

• KMID: 1714049
• DOI: http://doi.org/10.3346/jkms.2010.25.8.1231

Abstract

Minocycline is a semisynthetic tetracycline derivative that is often used in the treatment of acne vulgaris. To date, there has been only one case report of anaphylaxis to minocycline. We report here a case of anaphylaxis to oral minocycline. A 56-yr-old woman visited our hospital after three episodes of recurrent anaphylaxis. We performed an oral challenge test, the standard method for diagnosing drug allergies, with minocycline, one of the drugs she had taken previously. She developed urticaria, angioedema, nausea, vomiting, hypotension, and dyspnea within 4 min and was treated with intramuscular epinephrine, intravenous antihistamine and systemic corticosteroid. However, she presented similar symptoms at 50 min and at 110 min. In prescribing oral minocycline, physicians should consider the possibility of serious adverse reactions, such as anaphylaxis.

Keyword

Anaphylaxis; Minocycline; Oral Challenge Test; Allergy

MeSH Terms

Administration, Oral
Anaphylaxis/chemically induced/*diagnosis
Anti-Bacterial Agents/*adverse effects
Drug Hypersensitivity/diagnosis
Female
Humans
Middle Aged
Minocycline/*adverse effects
Recurrence

Figure

• 

  Fig. 1 Development of periorbital and perioral angioedema within 4 min after taking oral minocycline.

• 

  Fig. 2 Changes in blood pressure following an oral minocycline challenge test. Arrows indicate times at which drugs were administered, including epinephrine, antihistamine, and systemic corticosteroids.

Reference

1. Adkinson NF Jr, Essayan D, Gruchalla R, Haggerty H, Kawabata T, Sandler JD, Updyke L, Shear NH, Wierda D. Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions. J Allergy Clin Immunol. 2002. 109:S461–S478.

2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998. 279:1200–1205.

3. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995. 273:214–219.

4. Barnett CF Jr. Anaphylactoid reaction to orally administered tetracycline. South Med J. 1967. 60:963.

5. Goulden V, Glass D, Cunliffe WJ. Safety of long-term high-dose minocycline in the treatment of acne. Br J Dermatol. 1996. 134:693–695.

6. Clayton BD, Hitchcock MG, Williford PM. Minocycline hypersensitivity with respiratory failure. Arch Dermatol. 1999. 135:139–140.

7. Colvin JH, Sheth AP. Minocycline hypersensitivity syndrome with hypotension mimicking septic shock. Pediatr Dermatol. 2001. 18:295–298.

8. Okano M, Imai S. Anaphylactoid symptoms due to oral minocycline. Acta Derm Venereol. 1996. 76:164.

9. Chaudhuri K, Gonzales J, Jesurun CA, Ambat MT, Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth. 2008. 17:350–357.

10. Raeder JC. Anaphylactoid reaction caused by intravenous doxycycline during general anesthesia and beta-blockade treatment. Drug Intell Clin Pharm. 1984. 18:481–482.

11. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol. 1996. 132:934–939.